In two different studies, using either genetic FAP ablation or a DNA vaccine directed against FAP, improved recruitment of CD8+ T-cells and prolonged survival in murine models of lung, colon and pancreatic cancer [78,79]. The gene discussed is CD8A; the disease is pancreatic neoplasm.